All Search Results
-
SkyPASS: A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated with Lonapegsomatropin
SkyPASS: A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated with Lonapegsomatropin
-
Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized
-
Is Your Child Ready To Walk to School?
Is your child ready to walk to school? It can be scary for parents to make that decision, but teaching your child some basic rules and safety tips can help ease your concerns.
-
Tech and your kids: how much is too much?
In today’s digital era, tech devices have taken on a whole new role (and meaning). They have become kids’ most popular accessory and prized possession. iPhones, iPods, laptops, tablets- you name it and it is almost guaranteed that the kid sitting next to you has access to it. But why have these tech devices become so popular? Simple. They are an easily accessible way to entertain kids of all ages for hours on end- from the short trip to the grocery store, to the much-anticipated family road trip. While these devices can come in handy and better yet, to kids, how do parents decide when enough in enough?
-
How Much Is Too Much Protein for Your Child?
There is such a thing as too much protein — and it can be dangerous for your child. With the popularity of protein shakes and supplements, it’s important for parents to understand how to monitor protein intake and choose the best sources of this essential nutrient.
-
Improving Care of Children with Complex Congenital Heart Disease
National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children with Complex Congenital Heart Disease
-
Cystic Fibrosis National Registry
Cystic Fibrosis National Registry
-
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma
-
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
A Phase II study of Naxitamab added to induction Therapy for Subjects with Newly Diagnosed High Risk Neuroblastoma
-
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
